Le Lézard
Classified in: Mining industry, Health
Subject: PER

KitoTech Medical Announces Jeff Willis Has Joined as Its Chief Commercial Officer


SEATTLE, July 26, 2021 /PRNewswire-PRWeb/ -- KitoTech Medical, manufacturer of the microMend® Wound Closure Product, announces today that Jeff Willis, an experienced executive in the wound closure space, has joined KitoTech as its Chief Commercial Officer. He brings over 20 years of commercial experience in the medical device industry. From 2005 to 2021, Jeff was at Advanced Medical Solutions Group plc (AMS), an advanced wound closure and wound care company with a $850 million market cap. Most recently, he was a key member of the company's senior management team and Global Business Unit Director for Surgical Products where he led all Sales, Marketing and R&D functions. Jeff brings extensive global experience in launching and managing new wound closure products including one that has grown to over $50 million in annual end market sales. During his tenure, the stock price of AMS increased over 30-fold.

Jeff said, "This is a market I know well, and I believe that microMend has the potential to be a game-changer. It addresses many of the limitations of current wound closure products such as staples and sutures while also providing several new-to-category benefits. microMend is also backed by impressive clinical data and has enjoyed a great initial market response. I look forward to leading KitoTech's efforts to expand microMend into the many markets in which it can be used."

Ron Berenson, MD, President and CEO, stated: "Jeff has a proven record of success in the wound closure products business making him ideal to lead KitoTech's commercial efforts. He has previously demonstrated that he can successfully launch innovative products into the market, grow market share, and drive sales. Jeff has a unique background with experience in both of our markets - medical and consumer. His prior experiences, including building and managing a major sales and marketing organization, will be a tremendous asset to KitoTech as we move forward."

About KitoTech Medical and microMend

KitoTech Medical is a medical device company that has developed and commercialized microMend, a patented wound closure product, which consists of an array of miniature stainless steel staples (Microstaples) attached to an adhesive backing that combines the holding strength of a suture with the simplicity of applying a bandage. It is designed to provide medical personnel with a cost-effective, time saving and easy-to-use option for closing lacerations, skin tears, surgical incisions, and other wounds. microMend's consumer products make it possible for people to painlessly close lacerations without the inconvenience and costs associated with ER and Urgent Care Clinic visits. Additional product and company information can be found online at http://www.micromendskinclosure.com.

Media Contact

Ronald Berenson, MD, KitoTech Medical, Inc., +1 877-420-1502, [email protected]

Facebook

 

SOURCE KitoTech Medical, Inc.


These press releases may also interest you

at 15:15
Gustavo Manriquez, Chief Executive Officer, Banco Macro, Argentina, and his team joined Guillaume Legare, Head, South America, Toronto Stock Exchange, to open the market and celebrate the 2024 Banco Macro Mining Conference.   The 3rd annual Banco...

at 12:00
Jean-François Verret has been appointed Vice President, Raglan Mine, marking the beginning of a new chapter for the site following the retirement of Pierre Barrette, who leaves us a remarkable legacy....

at 09:20
Western Alaska Minerals (the " Company " or " WAM ") is pleased to announce that it has closed its previously announced brokered offering by way of prospectus supplement dated April 22, 2024 to the Company's base shelf prospectus...

at 08:35
IperionX Limited is pleased to announce a significant milestone in the development of commercial-scale titanium metal manufacturing capabilities at the Titanium Manufacturing Campus in Virginia. The Hydrogen Assisted Metallothermic Reduction (HAMR...

at 08:30
Alphamin Resources Corp. (AFM:TSXV, APH:JSE AltX)( "Alphamin" or the "Company") announced today that its Board of Directors has declared a Final FY2023 cash dividend of CAD$0.03 per share on the common shares (approximately US$27.9 million in the...

at 08:30
Standex International Corporation  will announce its third quarter fiscal 2024 financial results on Thursday, May 2, 2024 after the close of the market and will broadcast its conference call live over the Internet at 8:30 a.m. ET on Friday, May 3,...



News published on and distributed by: